SHA:603456 Market Cap

SHA:603456 has a market cap or net worth of 14.66 billion as of March 9, 2026. Its market cap has increased by 18.00% in one year.

Market Cap

14.66B

Enterprise Value

12.16B

Revenue

5.36B

Ranking

n/a

PE Ratio

20.31

Stock Price

16.63

Market Cap Chart

Since October 10, 2014, SHA:603456's market cap has increased from 4.62B to 14.66B, an increase of 217.59%. That is a compound annual growth rate of 10.65%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	14.66B	-7.09%
Dec 31, 2025	15.78B	28.87%
Dec 31, 2024	12.25B	-43.76%
Dec 29, 2023	21.78B	-38.48%
Dec 30, 2022	35.40B	-24.43%
Dec 31, 2021	46.84B	62.49%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Guobang Pharma	14.74B
Shanghai Shyndec Pharmaceutical	14.52B
Hybio Pharmaceutical	15.19B
Shenzhen Hepalink Pharmaceutical Group	15.29B
Guangdong Zhongsheng Pharmaceutical	15.31B
ApicHope Pharmaceutical Group	14.33B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.65B
Nanjing King-Friend Biochemical Pharmaceutical	15.66B

Market Cap Rankings